Skip to main content
San Francisco homeNews home
Story

Novo Nordisk A/S (NVO): “How Could They Be So Far Behind?,” Wonders Jim Cramer

Ramish Cheema

2 min read

In This Article:

Novo Nordisk A/S (NYSE:NVO) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks.

Novo Nordisk A/S (NYSE:NVO) is a Danish pharmaceutical giant that is a key player in the weight loss drug market. The firm’s shares have lost 15.7% year-to-date. Novo Nordisk A/S (NYSE:NVO) has struggled primarily due to investor fears about Eli Lilly overtaking the firm in the weight loss drug market. Other news, such as a surprise departure of the firm’s CEO hasn’t helped the stock pare back its losses either. Novo Nordisk A/S (NYSE:NVO)’s stock lost 6% in March after its CagriSema weight loss drug fell short of the firm’s estimates. While it had expected the drug to help users lose 25% of their body weight, the trials led to a 15.7% weight reduction. Cramer commented on activist investor Parvus taking a stake in the company:

[On activist fund Parvus building a stake in the company] How could they be so far behind? You know they were first, they were first mover. And then Lilly came along, Lilly by the way, still a great stock. But maybe this is going to shake up Novo.

In his previous comments about Novo Nordisk A/S (NYSE:NVO), Cramer commented on the firm in the context of Eli Lilly:

Novo Nordisk A/S (NVO): "How Could They Be So Far Behind?," Wonders Jim Cramer

Novo Nordisk A/S (NVO): "How Could They Be So Far Behind?," Wonders Jim Cramer

An elderly couple receiving insulin from a pharmacist, representing healthcare company's successful pharmaceutical products.

“Okay, Eli Lilly. We bought some just the other day for the Charitable Trust. Why did we do that? Because it’s down very big and yet it’s been beating Novo Nordisk over and over and over again. So I just think this is a decent level to start a position if you don’t have any.”

While we acknowledge the potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.